About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Multiomics Tumor Evolution Model of NSCLC | Clinical Trials | Clareo Health

Back to clinical trial search

RECRUITINGNCT05352035

Multiomics Tumor Evolution Model of NSCLC

The purpose of this study is to determine the evolutionary mechanism of early-stage non-small cell lung cancer and establish an accurate prognostic model and a recurrence monitoring system by multiomi...

Lead sponsor: Peking University People's Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Kezhong Chen, M.D.

CONTACT

+86-010-88326657 chenkezhong@pkuph.edu.cn

Wenxiang Wang

CONTACT

+86-010-88326657 wangwenxiang@stu.pku.edu.cn

Sponsors

Lead Sponsor

Peking University People's Hospital

Collaborators

Chinese Academy of Medical Sciences

Lung cancer is the leading cause of cancer-related death globally. Non-small cell lung cancer (NSCLC) accounts for 85% of lung cancer and surgery is still the main treatment strategy. This study will determine the evolutionary mechanism of early-stage non-small cell lung cancer and establish an accurate prognostic model and a recurrence monitoring system by multiomics analysis, which can be helpful for the individual and whole management of lung cancer patients and improve the overall prognosis.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Age ≥ 18 years old;
•2. Early-stage NSCLC patients underwent radical surgical resection;
•3. Sufficient tumor tissue and blood sample for study use;
•4. Available clinical-pathologic data, imaging data and follow-up date;
•5. Written informed consent.

Exclusion Criteria

•1. History of other malignant tumors;
•2. Evidence of distant metastasis before surgery;
•3. Insufficient tumor tissue or blood sample for study use;
•4. Clinical-pathologic data, imaging data or follow-up date is not available;
•5. Other judgments by the Investigator that the patient should not participate in the study.

Related studies

Characterization of Multi-Omics Landscapes and AI Pathological Prediction Model for Long-Term Survival in NSCLC Immunotherapy

NCT07668037 · Non-Small Cell Carcinoma of Lung, Immunotherapy, and more

Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols

NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more

RECRUITINGPhase 1

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

NCT06529822 · Muscle-Invasive Bladder Carcinoma, Gastroesophageal Adenocarcinoma, and more

RECRUITINGPhase 2

A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Glecirasib

NCT07164170 · Non-Small Cell Lung Cancer

Hybrid Prehabilitation Before Thoracic Surgery

NCT06866717 · Non-Small Cell Lung Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 30, 2025Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment300

Start dateApr 2022

Last updatedApr 30, 2025

Condition

Non-small Cell Lung Cancer

Locations shown

Peking University People's Hospital

Beijing

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 30, 2025Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions